Session Details

Quality & Operations Track Session 2 - Managing the Mushrooming Growth in Cell and Gene Therapy
Friday, September 13, 2019 10:45 AM - 12:15 PM
Ballroom B
You would be hard pressed to find someone working in cell and gene therapy today who is not experiencing unprecedented growth and demands for their services and expertise. This session will gather cell therapy professionals from multiple disciplines to discuss the challenges they are currently facing and what approaches they are using – or planning to use.  Program leaders in charge of growing a pre-clinical and clinical research pipeline and the professionals – such as business/ facility/ quality managers or directors – who are responsible for building, opening and maintaining that pipeline will all be represented. Audience members will be invited to participate in the topics and discussions through use of the app and/or an active Q&A session.

Learning Objectives
•      Hear statistics from multiple centers on current and projected growth patterns
•      Understand the opportunities, concerns and approaches being used by various stakeholders to manage and even excel at growth

Chair: Lynn O'Donnell, PhD, Ohio State University, James Cancer Hospital Columbus, USA

Eric Gilles, Mayo Clinic IMPACT, USA

Kathryn Melsop, Stanford Laboratory for Cell & Gene Medicine, USA

Rosemarie Bell, B.App.Sc Micro/Biochem MASM, QIMR Berghofer Medical Research Institute/ Q-Gen Cell Therapeutics, Australia

Jacques Galipeau, MD, University of Wisconsin - Madison, USA